A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines

Completed · Not applicable · Has a placebo group

Conditions studied: Fine Lines, Wrinkles, Photoaging

In brief

This randomized, double-blind, placebo-controlled clinical trial was conducted to assess the efficacy and safety of an anti-aging serum to improve the appearance of expression lines as well as overall skin health of aging skin after 12 weeks of twice-daily use in female subjects, aged 35-60, compared to placebo. A total of 55 subjects completed study participation which included 33 subjects in the active group and 22 subjects in the placebo group.

Key facts

Study ID

NCT04545970

Run by

Revision Skincare

People needed

56

Starts

2019-12-23

Expected to finish

2020-07-06

Last updated by the study team

2020-09-16

Who can join

Age: 35 and older, up to 60. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women between the ages of 35 and 60 years were scheduled for eligibility screening at the study site.
• Women with Fitzpatrick Skin Type I-VI
• Subjects must have mild to moderate global face wrinkles and fine lines
• Subjects may have mild to moderate photo-aging secondary to physiologic aging
• Subjects must have no known medical conditions that, in the investigator's opinion, may interfere with study participation.
• Subjects must be willing to provide verbal understanding and written informed consent.

You may not qualify if…

• Female subjects who are pregnant, breast feeding, or planning a pregnancy.
• Subjects with severe overall photo damage as determined by the Investigator.
• Subjects who have any dermatological disorder, which in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin, including rosacea, acne, and excessively oily or dry skin.
• Subjects who have demonstrated a previous hypersensitivity reaction to any of the ingredients of the study products.
• Subjects use of any medications that are known to potentially cause changes in the facial skin as determined by the Investigator.
• Subjects who spend excessive time out in the sun.
• Subjects who are unwilling or unable to comply with the requirements of the protocol.

Where it is running

• Ablon Skin Institute Research Center — Manhattan Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.